Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EOLS

Evolus (EOLS)

Evolus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateTimeSourceHeadlineSymbolCompany
03/04/20254:44PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
03/04/20254:40PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EOLSEvolus Inc
03/04/20254:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
02/27/20258:00AMBusiness WireEvolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor ConferencesNASDAQ:EOLSEvolus Inc
02/20/20258:00AMBusiness WireEvolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness SummitNASDAQ:EOLSEvolus Inc
02/18/20258:00AMBusiness WireEvolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025NASDAQ:EOLSEvolus Inc
02/13/20251:30PMBusiness WireEvolus Announces FDA Approval of Evolysseâ„¢ Form and Evolysseâ„¢ Smooth Injectable Hyaluronic Acid GelsNASDAQ:EOLSEvolus Inc
02/07/20257:09PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
02/06/20254:16PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:EOLSEvolus Inc
01/21/20258:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
01/21/20258:00AMBusiness WireEvolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company’s GuidanceNASDAQ:EOLSEvolus Inc
01/17/20254:05PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
12/26/20245:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
12/26/20245:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
12/13/20244:05PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
11/06/20245:22PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
11/06/20244:37PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
11/06/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
11/06/20244:05PMBusiness WireEvolus Reports Third Quarter 2024 ResultsNASDAQ:EOLSEvolus Inc
11/01/20248:00AMBusiness WireEvolus to Participate in Stifel 2024 Healthcare ConferenceNASDAQ:EOLSEvolus Inc
10/31/20242:02PMBusiness WireEvolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device RegulationNASDAQ:EOLSEvolus Inc
10/29/20248:00AMBusiness WireEvolus Rewardsâ„¢ Patient Loyalty Program Surpasses 1 Million Enrolled ConsumersNASDAQ:EOLSEvolus Inc
10/23/20248:00AMBusiness WireEvolus to Report Third Quarter Financial Results on November 6, 2024NASDAQ:EOLSEvolus Inc
10/11/202410:53PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
09/27/20249:00PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
09/06/20249:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/06/20249:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/06/20248:00AMBusiness WireEvolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024NASDAQ:EOLSEvolus Inc
09/04/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
08/09/20244:30PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS